文献速递眼底病与葡萄膜炎

临床实践中部署智能手机居家视力监测的促进因素与障碍

Enablers and Barriers to Deployment of Smartphone-Based Home Vision Monitoring in Clinical Practice Settings.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

这项队列和调查研究纳入2020年5月至2021年2月在Moorfields眼科医院接受玻璃体内注射的417例连续成人患者,提供Home Vision Monitor(HVM)智能手机应用自我检测视力。61.9%为活跃用户,摄取率与年龄负相关、与较好眼视力和基线注射次数正相关;依从性与新生血管性年龄相关性黄斑变性、White British族裔和基线较好眼视力相关;使用率随对现代技术使用的舒适度升高而增高。

要点

  • 417例接受玻璃体内注射的患者中258例(61.9%)为活跃用户,摄取率与年龄负相关(OR,0.98)。
  • 258例活跃患者中166例(64.3%)符合依从性定义,依从性与新生血管性年龄相关性黄斑变性相关(OR,1.94)。
  • 119例患者(98.4%)认为应用易于或非常易于使用,96例(82.1%)因使用应用而获得更多 reassurance。

核心结论

  • 在临床实践环境中对常见威胁视力疾病患者进行居家视力监测评估,揭示了与患者摄取和参与相关的人口学、临床和患者相关因素。

研究设计与样本

  • 队列和调查研究,连续纳入2020年5月至2021年2月在Moorfields眼科医院接受玻璃体内注射治疗视网膜疾病的成人患者,共417例。

主要发现

  • 417例患者中236例(56.6%)为女性,平均(SD)年龄72.8(12.8)岁,258例(61.9%)为活跃用户。
  • 摄取率与年龄负相关(OR,0.98;95%CI,0.97-0.998;P=0.02),与较好眼视力正相关(OR,1.02;95%CI,1.00-1.03;P=0.01),与基线玻璃体内注射次数正相关(OR,1.01;95%CI,1.00-1.02;P=0.02)。
  • 258例活跃患者中166例(64.3%)符合依从性定义,依从性与新生血管性年龄相关性黄斑变性相关(OR,1.94;95%CI,1.07-3.53;P=0.002),与White British族裔相关(OR,1.69;95%CI,0.96-3.01;P=0.02),与基线较好眼视力相关(OR,1.02;95%CI,1.01-1.04;P=0.04)。
  • 使用率随对现代技术使用的舒适度升高而增高(β=0.031;95%CI,0.007-0.055;P=0.02)。
  • 119例患者(98.4%)认为应用易于或非常易于使用,96例(82.1%)因使用应用而获得更多 reassurance。

临床怎么用

  • 这些见解为针对智能手机医疗设备数字排斥风险的靶向干预提供信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Telemedicine is accelerating the remote detection and monitoring of medical conditions, such as vision-threatening diseases. Meaningful deployment of smartphone apps for home vision monitoring should consider the barriers to patient uptake and engagement and address issues around digital exclusion in vulnerable patient populations. OBJECTIVE: To quantify the associations between patient characteristics and clinical measures with vision monitoring app uptake and engagement. DESIGN, SETTING, AND PARTICIPANTS: In this cohort and survey study, consecutive adult patients attending Moorfields Eye Hospital receiving intravitreal injections for retinal disease between May 2020 and February 2021 were included. EXPOSURES: Patients were offered the Home Vision Monitor (HVM) smartphone app to self-test their vision. A patient survey was conducted to capture their experience. App data, demographic characteristics, survey results, and clinical data from the electronic health record were analyzed via regression and machine learning. MAIN OUTCOMES AND MEASURES: Associations of patient uptake, compliance, and use rate measured in odds ratios (ORs). RESULTS: Of 417 included patients, 236 (56.6%) were female, and the mean (SD) age was 72.8 (12.8) years. A total of 258 patients (61.9%) were active users. Uptake was negatively associated with age (OR, 0.98; 95% CI, 0.97-0.998; P = .02) and positively associated with both visual acuity in the better-seeing eye (OR, 1.02; 95% CI, 1.00-1.03; P = .01) and baseline number of intravitreal injections (OR, 1.01; 95% CI, 1.00-1.02; P = .02). Of 258 active patients, 166 (64.3%) fulfilled the definition of compliance. Compliance was associated with patients diagnosed with neovascular age-related macular degeneration (OR, 1.94; 95% CI, 1.07-3.53; P = .002), White British ethnicity (OR, 1.69; 95% CI, 0.96-3.01; P = .02), and visual acuity in the better-seeing eye at baseline (OR, 1.02; 95% CI, 1.01-1.04; P = .04). Use rate was higher with increasing levels of comfort with use of modern technologies (β = 0.031; 95% CI, 0.007-0.055; P = .02). A total of 119 patients (98.4%) found the app either easy or very easy to use, while 96 (82.1%) experienced increased reassurance from using the app. CONCLUSIONS AND RELEVANCE: This evaluation of home vision monitoring for patients with common vision-threatening disease within a clinical practice setting revealed demographic, clinical, and patient-related factors associated with patient uptake and engagement. These insights inform targeted interventions to address risks of digital exclusion with smartphone-based medical devices.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Korot E, Pontikos N, Drawnel FM, et al. Enablers and Barriers to Deployment of Smartphone-Based Home Vision Monitoring in Clinical Practice Settings. JAMA Ophthalmol. 2022. PMID: 34913967. doi:10.1001/jamaophthalmol.2021.5269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。